Press Releases Mydecine Innovations Group Inc. NEO Exchange

Equities

MYCO

CA62849F2008

End-of-day quote NEO Exchange Other stock markets 23:00:00 05/10/2023 BST			5-day change	1st Jan Change
0.175 ^CAD	+45.83%		+29.63%	-61.11%

05-01	Mydecine Innovations Group Inc. announced that it expects to receive CAD 1 million in funding	CI
02-23	Mydecine Innovations Closes Partial Debt Settlement	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mydecine Applies for Management Cease Trade Order	05-03	AQ
Mydecine Receives Management Cease Trade Order	05-03	AQ
Mydecine Innovations Group Inc. Announces Restructuring Transactions and Annual General and Special Meeting	05-02	AQ
Mydecine Announces Intention to Refile Certain Financial Statements and Applies for Management Cease Trade Order	04-25	AQ
Mydecine Innovations Group Inc. Announces Share for Debt Settlement	03-20	AQ
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds	02-07	GL
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds	02-07	AQ
Mydecine Innovations Group Announces Director Resignation	02-02	GL
Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound	12-18	GL
Mydecine Announces Update Regarding the Special Access Program	11-28	GL
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements	31/10/23	GL
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements	31/10/23	AQ
Mydecine Provides Q4 2023 Business Update	26/10/23	GL
Mydecine Provides Q4 2023 Business Update	26/10/23	AQ
Mydecine Innovations Group gearing up for human trials after completing Aquis listing	18/10/23	AQ
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK	12/10/23	GL
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK	12/10/23	AQ
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings	10/10/23	AQ
Mydecine Innovations Group Announces Listing on the Canadian Securities Exchange and Delisting from the NEO	05/10/23	AQ
Mydecine Innovations Group Announces Expected U.K. Dual Listing Admission Date	27/09/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Mydecine Innovations Group Inc. NEO Exchange

Equities

MYCO

CA62849F2008

Press Releases

Filters